Reversible activation of secretory phospholipase A2 by sulthydryl reagents

被引:6
|
作者
Nabemoto, M
Ohsawa, K
Nakamura, H
Hirabayashi, T
Saito, T
Okuma, Y
Nomura, Y
Murayama, T [1 ]
机构
[1] Chiba Univ, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Chiba 2608675, Japan
[2] Hokkaido Univ, Sch Med, Lab Environm Biol, Sapporo, Hokkaido 0608638, Japan
[3] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido 0600812, Japan
关键词
arachidonic acid; secretory phospholipase A(2); sulfhydryl group; thimerosal; phenylarsine oxide; PC12; cells;
D O I
10.1016/j.abb.2005.02.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Secretory phospholipase A(2)s (sPLA(2)s) have been implicated in physiological and pathological events, but the regulatory mechanism(s) of their activities in cells remains to be solved. Previously, we reported that phenylarsine oxide (PAO), a sulfhydryl reagent, stimulated arachidonic acid (AA) release ill rat pheochromocytoma PC12 cells. In this study, we examined the effects of thimerosal, another sulfhydryl reagent, to clarify the sulfhydryl modification and activation of sPLA(2) molecules in cells. Like PAO, thimerosal-stimulated AA release in an irreversible manner and the responses were not additive. Dithiol compounds such as dithiothreitol inhibited AA release from both the thimerosal- and the PAO-treated cells, and monothiol compounds (L-Cys and glutathione) decreased the thimerosal response. Both sullfhydryl reagents stimulated AA release from the HEK293T cells expressing human sPLA(2)X, and stimulated the sPLA(2) activities of bee venom sPLA(2) and the soluble fraction of sPLA(2)X-expressing cells. Our results suggest that the sPLA(2)s in cells are inactive and rnodification of disulfide bonds in the molecules can be a trigger of sPLA(2) activation in cells. Sulfhydryl reagents are Useful tools for Studying the regulatory mechanism(s) of sPLA(2) activity ill cells. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:145 / 153
页数:9
相关论文
共 50 条
  • [1] Secretory phospholipase A2
    Murakami, M
    Kudo, I
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (08) : 1158 - 1164
  • [2] Dendritic-cell activation by secretory phospholipase A2
    Ramoner, R
    Putz, T
    Gander, H
    Rahm, A
    Bartsch, G
    Schaber, C
    Thurnher, M
    BLOOD, 2005, 105 (09) : 3583 - 3587
  • [3] Secretory phospholipase A2 in pRBCs
    Cardo, L. J.
    Swingholm, M.
    TRANSFUSION, 2007, 47 (03) : 94A - 94A
  • [4] Biology of Secretory Phospholipase A2
    Boyanovsky, Boris B.
    Webb, Nancy R.
    CARDIOVASCULAR DRUGS AND THERAPY, 2009, 23 (01) : 61 - 72
  • [5] Biology of Secretory Phospholipase A2
    Boris B. Boyanovsky
    Nancy R. Webb
    Cardiovascular Drugs and Therapy, 2009, 23
  • [6] Phospholipase A2 receptor:: a regulator of biological functions of secretory phospholipase A2
    Hanasaki, K
    Arita, H
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2002, 68-9 : 71 - 82
  • [8] Activation of Secretory A2 Phospholipase Isotypes and Surfactant Injury in Murine ARDS
    Hite, R.
    Novotny, M. V.
    Lee, J.
    Smallcombe, C. C.
    Furdui, C.
    Seeds, M. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [9] Secretory phospholipase A2 triggers activation of different pathways in astrocytoma cells
    Hernández, M
    Barrero, MJ
    Crespo, MS
    Nieto, ML
    MOLECULAR MECHANISMS OF SIGNAL TRANSDUCTION, 2000, 316 : 73 - 82
  • [10] Secretory Phospholipase A2 Responsive Liposomes
    Zhu, Guodong
    Mock, Jason N.
    Aljuffali, Ibrahim
    Cummings, Brian S.
    Arnold, Robert D.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (08) : 3146 - 3159